OTC Medicines

Now that the House of Representatives and the Senate HELP Committee have passed their respective FDA user fee bills, House and Senate negotiators have been working to conference and reconcile differences in both bills.

Industry executives from Europe and beyond gathered June 7-8, in Madrid, Spain, for the annual meeting of the Association of the European Self-Care Industry (AESGP), its first annual meeting since 2019. Under the theme “supporting innovation in self-care during times of uncertainty,” speakers focused on the European context of environmental sustainability, trends shaping the future of the consumer healthcare business, and the outlook for changes to the EU’s pharmaceutical framework, among other topics.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Awareness of acetaminophen safe use and the risks of using too much remains high, indicating that ongoing education is critical to continued progress.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

CHPA has issued a statement in response to a recent, observational NSAID study published in the journal Science Translational Medicine.